Skip to Main Content

Paper Details

FDA-led consortium studies advance quality control of targeted next generation sequencing assays for precision oncology.
Precis Cancer Med
1
2021
Cancer, RNA, patient, tumor
Author NameAffiliation
Rebecca KuskoImmuneering Corporation
Baitang NingNational Center for Toxicological Research
Weida TongNational Center for Toxicological Research
Weida TongNational Center for Toxicological Research
Donald J JohannWinthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Joshua XuNational Center for Toxicological Research
  • 1 - 6

Datasets

Release 1.2